TaiMed Biologics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	763.72	898.38	580.23	251.01	274.11	551.62
Short-Term Investments	871.03	869.64	1,072	395.49	309.93	406.68
Trading Asset Securities	-	-	-	-	58.75	-
Cash & Short-Term Investments	1,635	1,768	1,652	646.5	642.79	958.3
Cash Growth	-2.46%	7.00%	155.58%	0.58%	-32.92%	-20.21%
Accounts Receivable	88.67	79.06	103.02	160.49	98.24	157.78
Other Receivables	50.75	48.41	31.3	28.16	25.49	35.41
Receivables	139.42	127.48	134.31	188.65	123.73	193.19
Inventory	1,380	1,399	1,569	1,271	1,389	1,177
Prepaid Expenses	18.09	21.92	6.41	10.01	4.15	3.54
Other Current Assets	6.41	6.28	31.16	35.63	5.08	2.59
Total Current Assets	3,179	3,322	3,394	2,151	2,165	2,335
Property, Plant & Equipment	797.38	807.39	857.4	908.26	957.74	1,011
Long-Term Investments	16	15.72	-	0.9	43.44	232.63
Other Intangible Assets	418.04	442.15	539.4	625.79	724.38	821.33
Other Long-Term Assets	223.34	223.18	208.79	207.58	210.57	211.19
Total Assets	4,634	4,811	4,999	3,894	4,101	4,611
Accounts Payable	13.07	81	0.76	13.5	0.09	122.58
Accrued Expenses	14.85	16.66	11.63	7.49	39.39	51.64
Short-Term Debt	-	-	-	200	200	-
Current Portion of Long-Term Debt	27.99	27.84	27.24	26.97	14.32	-
Current Portion of Leases	2.29	2.29	2.26	2.18	2.02	1.95
Current Unearned Revenue	106.12	106.29	74.32	91.12	57.48	24.34
Other Current Liabilities	24.64	19.43	18.56	19.92	16.57	24.57
Total Current Liabilities	188.95	253.51	134.77	361.17	329.86	225.08
Long-Term Debt	433.13	440.19	468.03	495.04	521.68	536
Long-Term Leases	22.24	22.81	25.1	26.67	28.12	29.38
Long-Term Unearned Revenue	192.01	236.55	347.53	444.04	505.6	877.9
Other Long-Term Liabilities	-	-	0.92	0.92	0.92	0.87
Total Liabilities	836.32	953.05	976.34	1,328	1,386	1,669
Common Stock	2,732	2,732	2,731	2,530	2,526	2,523
Additional Paid-In Capital	2,472	2,469	2,452	986.67	945.45	925.14
Retained Earnings	-1,288	-1,304	-1,136	-934.56	-740.22	-470.93
Comprehensive Income & Other	-36.25	-38.88	-23.89	-16.13	-15.83	-35.97
Shareholders' Equity	3,798	3,858	4,023	2,566	2,715	2,942
Total Liabilities & Equity	4,634	4,811	4,999	3,894	4,101	4,611
Total Debt	485.65	493.12	522.63	750.86	766.14	567.32
Net Cash (Debt)	1,149	1,275	1,130	-104.35	-123.35	390.98
Net Cash Growth	-0.99%	12.86%	-	-	-	-38.12%
Net Cash Per Share	4.21	4.67	4.21	-0.41	-0.49	1.55
Filing Date Shares Outstanding	273.2	273.2	273.08	253.01	252.55	252.33
Total Common Shares Outstanding	273.2	273.2	273.08	253.01	252.55	252.33
Working Capital	2,990	3,069	3,259	1,790	1,835	2,110
Book Value Per Share	13.90	14.12	14.73	10.14	10.75	11.66
Tangible Book Value	3,380	3,416	3,484	1,940	1,991	2,120
Tangible Book Value Per Share	12.37	12.50	12.76	7.67	7.88	8.40
Land	194.61	194.61	194.61	194.61	194.61	194.61
Buildings	497.93	497.93	495.41	493.95	493.54	493.12
Machinery	462.83	458.82	457.35	455.56	450.03	446.9
Leasehold Improvements	4.64	4.64	4.64	4.64	4.64	4.64